Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

B López, S Ravassa, MU Moreno, GS José… - Nature Reviews …, 2021 - nature.com
Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through
the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion …

Myocardial interstitial fibrosis in heart failure: biological and translational perspectives

A González, EB Schelbert, J Díez, J Butler - Journal of the American …, 2018 - jacc.org
Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …

Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial

AA Kalstad, PL Myhre, K Laake, SH Tveit, EB Schmidt… - Circulation, 2021 - Am Heart Assoc
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been
associated with reduced risk of cardiovascular events; however, this has not been confirmed …

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors

K Lechner, C von Schacky… - European journal of …, 2020 - journals.sagepub.com
Despite major efforts to reduce atherosclerotic cardiovascular disease (ASCVD) burden with
conventional risk factor control, significant residual risk remains. Recent evidence on non …

[HTML][HTML] Biomaterials from the sea: Future building blocks for biomedical applications

M Wan, W Qin, C Lei, Q Li, M Meng, M Fang, W Song… - Bioactive Materials, 2021 - Elsevier
Marine resources have tremendous potential for developing high-value biomaterials. The
last decade has seen an increasing number of biomaterials that originate from marine …

Blood omega-3 fatty acids and death from COVID-19: A pilot study

A Asher, NL Tintle, M Myers, L Lockshon… - … and Essential Fatty …, 2021 - Elsevier
Very-long chain omega-3 fatty acids (EPA and DHA) have anti-inflammatory properties that
may help reduce morbidity and mortality from COVID-19 infection. We conducted a pilot …

Inflammation in human heart failure: major mediators and therapeutic targets

M Reina-Couto, P Pereira-Terra… - Frontiers in …, 2021 - frontiersin.org
Inflammation has been recognized as a major pathophysiological contributor to the entire
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …

An update on omega-3 polyunsaturated fatty acids and cardiovascular health

A Elagizi, CJ Lavie, E O'Keefe, K Marshall, JH O'keefe… - Nutrients, 2021 - mdpi.com
Interest in the potential cardiovascular (CV) benefits of omega-3 polyunsaturated fatty acids
(Ω-3) began in the 1940s and was amplified by a subsequent landmark trial showing …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases

WH Schunck, A Konkel, R Fischer… - Pharmacology & …, 2018 - Elsevier
Numerous benefits have been attributed to dietary long-chain omega-3 polyunsaturated fatty
acids (n-3 LC-PUFAs), including protection against cardiac arrhythmia, triglyceride-lowering …